Crossmark

Emerging therapies for small cell lung cancer

Crossref DOI link: https://doi.org/10.1186/s13045-019-0736-3

Published Online: 2019-05-02

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Sen

Zhang, Zhe

Wang, Qiming http://orcid.org/0000-0003-3217-1077
Funding

Funding for this research was provided by:

Medical Science and Technology Foundation of Henan Province (201601026)

National Natural Science Foundation of China (81272600)

Henan Provincial Training Abroad Foundation for Leaders of Medical Science (201082)

Henan Provincial Special Funds for Health and Technological Innovative Talents (2011020155)

Henan Provincial Research Program of Application Foundation and Advanced Technology (112300410033)

Henan Province and Ministry of Health of Medical Science and Technology Program (201601026)

the 51282 project Leading Talent of Henan Provincial Health Science and Technology Innovation Talents ([2016]32)

Wu Jieping Medical Foundation for Clinical Research (320.6799.15018)

Program for Science and Technology Innovation Talents in Universities of Henan Province (18HASTIT044)
License Information

Text and Data Mining valid from 2019-05-02
More Information

Article History

Received: 7 March 2019

Accepted: 18 April 2019

First Online: 2 May 2019

Ethics approval and consent to participate

: Not applicable.

: Written informed consent for publication was obtained from both participants.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.